EssilorLuxottica 1Q 2021 Revenue Rises 7.3 Percent, to €4.1 Billion

By Staff
Friday, May 7, 2021 12:33 AM EssilorLuxottica’s revenue rises for Q1, some positive business trends emerge for practices, Vision Expo extends free registration, Midwest Vision Partners announces a partnership and Rx Optical and MyEyeDr. strike a deal all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

EssilorLuxottica 1Q 2021 Revenue Rises 7.3 Percent, to €4.1 Billion

By Staff
Friday, May 7, 2021 12:30 AM CHARENTON-LE-PONT, France—EssilorLuxottica (Reuters: ESLX.PA) returned to growth during first quarter 2021, posting consolidated revenue totaling €4,060 million, a year-on-year increase of 7.3 percent compared to the first quarter of 2020 (+14.3 percent at constant exchange rates). Consolidated revenue grew by 1.9 percent at constant exchange rates compared to the first quarter of 2019.

Bausch Health Reports Slight Sales Gain in First Quarter and Provides Details on Expected Leadership Team for B+L Business

By Staff
Wednesday, May 5, 2021 12:27 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) reported Tuesday that its full-company revenue rose 1 percent (or $15 million) in the first quarter to $2.027 billion from $2.012 billion in the year-ago period.

Bausch Health May Consider Potential Sale of the Bausch + Lomb Eyecare Business, According to Report

By Staff
Friday, April 30, 2021 12:39 AM Bausch Health may sell B+L eyecare biz, Eye Health America continues Southeast expansion, optical sales continue to decline, Jobson Tracker says, EssilorLuxottica to exhibit at Expo as fully integrated company and more than 200 exhibitors commit to Vision Expo East all topped this week’s VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.

Bausch Health May Consider Potential Sale of the Bausch + Lomb Eyecare Business, According to Report

By Staff
Friday, April 30, 2021 12:36 AM LAVAL, Quebec—Bausch Health Companies (NYSE/TSX: BHC) is weighing the potential sale of its Bausch + Lomb eyecare business, rather than spinning off the business to shareholders as the company planned, according to a Bloomberg report earlier this week. The news service cited “people with knowledge of the matter” as the origin of its report. Bausch Health declined comment on the report, a spokeswoman told VMAIL.

Safilo Group Shareholders' Meeting Approves Year-End Results and New Board of Directors Reaffirms Angelo Trocchia as CEO

By Staff
Friday, April 30, 2021 12:30 AM PADOVA, Italy—The shareholders' meeting of Safilo Group S.p.A. (SFLG.MI) met Thursday to approve the company's year-end 2020 financial statements and approve a new board of directors, as well as new rules related to the board.

Inspecs Group Provides Trading Update for Q1

By Staff
Friday, April 30, 2021 12:24 AM BATH, England—Inspecs Group plc (LSE: SPEC), a leading designer, manufacturer and distributor of eyewear frames, announced Thursday a trading update for the three-month period ending March 31.

CooperVision Acquires No7 Contact Lenses to Expand Specialty EyeCare Business and Establish Direct-to-ECP Presence in the U.K.

By Staff
Wednesday, April 28, 2021 12:21 AM FAREHAM, United Kingdom—CooperVision reported Tuesday that it has acquired No7 Contact Lenses, which is based here. No7 Contact Lenses designs and manufactures specialty contact lenses that are distributed primarily in the United Kingdom.

GrandVision Reports Slight Sales Decline in Q1, But Notes Customers’ Inclination for ‘Higher-Value Products’

By Staff
Monday, April 26, 2021 12:24 AM SCHIPHOL, The Netherlands—GrandVision NV (Euronext: GVNV) reported Friday that its sales in the first quarter fell 0.7 percent to €899 million from €926 million in the first quarter of 2020, with comparable revenue declining 1.5 percent compared with the year-ago first quarter.

Nanodropper Completes $1.4 Million Seed Funding Round

By Staff
Monday, April 26, 2021 12:18 AM ROCHESTER, Minn.—Nanodropper, Inc., a medical device company offering a first-of-its-kind eyedrop bottle adaptor that reduces eyedrop size, recently completed a $1.4 million seed round.

Tesseract Health Closes Oversubscribed $80 Million Series B Financing

By Staff
Thursday, April 22, 2021 12:18 AM GUILFORD, Conn.—Tesseract Health has raised $80 million in an oversubscribed Series B financing round. The funds will be used to advance the development of the company’s Tesseract iC eye-imaging diagnostic technology platform, accelerate its push to obtain U.S. and international regulatory clearances, and ramp up manufacturing, the company said in a statement. The funds will also be used to further enhance Tesseract’s unique AI capabilities and prepare the company for commercial launch. The funding round was supported by investors including Foresite Capital, Glenview Capital, and Opaleye.

Johnson & Johnson Reports Strong First Quarter as Medical Devices Segment Sees ‘Continued Recovery’

By Staff
Wednesday, April 21, 2021 12:18 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported Tuesday that its first-quarter sales increased 7.9 percent to $22.3 billion, with operational sales growth of 5.5 percent.

Binovi to Acquire Computer Aided Vision Therapy (CAVT)

By Staff
Tuesday, April 20, 2021 12:27 AM VANCOUVER, BC—Binovi Technologies Corp. (TSX-V:VISN), a leader in neuro-vision performance technology, has entered into an “arm's length” share purchase agreement with the shareholders of Samurai Motion Tracking Corp., a software-based vision therapy company providing computer- aided vision therapy resources headquartered here. Binovi has agreed to pay CDN $2,516,000 Canadian for all the issued and outstanding share capital of Samurai, payable by the issuance of 31,450,000 common shares of Binovi at a price of CDN$0.08 per consideration share to Samurai shareholders. The acquisition is subject to TSX Venture Exchange approval.

BonLook Acquires EyeMeasure, an Optical Measurement App

By Staff
Monday, April 19, 2021 12:27 AM MONTREAL—BonLook, the Montreal-based eyewear retailer, announced that it has acquired EyeMeasure, an application that measures a patient’s PD and seg height. The app, which can also be used with iPad, iPhone or iPhone X, includes virtual try-on and frame digitization. The terms of the deal were not announced. “Innovation is one of BonLook’s core values, and this new acquisition allows us to move closer to our objective of improving eyecare service and prescription eyewear purchase accessibility in-store and online,” said Louis-Felix Boulanger, BonLook’s chief operating officer and co-founder.

Innovega Receives Securities and Exchange Commission Qualification for $15 Million Offering

By Staff
Friday, April 16, 2021 12:24 AM BELLEVUE, Wash.—Innovega Inc. received SEC qualification for its $15 million Regulation A+ offering which set in motion the conversion of reservations to completed investments.